Cite
HARVARD Citation
Wilson, A. et al. (2020). Successful remission induction therapy with gilteritinib in a patient with de novo FLT3‐mutated acute myeloid leukaemia and severe COVID‐19. British journal of haematology. pp. e189-e191. [Online].